eFFECTOR Therapeutics, Inc.
EFTR
$0.0002
$0.000.00%
OTC PK
| 03/31/2024 | 12/31/2023 | 09/30/2023 | 06/30/2023 | 03/31/2023 | |
|---|---|---|---|---|---|
| Net Income | -34.63M | -35.81M | -35.94M | -37.20M | -35.75M |
| Total Depreciation and Amortization | 111.00K | 111.00K | 108.00K | 100.00K | 76.00K |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 4.38M | 4.47M | 4.69M | 5.14M | 3.97M |
| Change in Net Operating Assets | 954.00K | 1.69M | 383.00K | 763.00K | 4.67M |
| Cash from Operations | -29.19M | -29.55M | -30.76M | -31.19M | -27.04M |
| Capital Expenditure | -84.00K | -97.00K | -56.00K | -99.00K | -148.00K |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -780.00K | 14.58M | 9.22M | 14.80M | 19.59M |
| Cash from Investing | -864.00K | 14.48M | 9.16M | 14.70M | 19.44M |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -556.00K | -- | -- | -- | -- |
| Issuance of Common Stock | 35.81M | 21.23M | 15.12M | 14.89M | 323.00K |
| Repurchase of Common Stock | -- | -- | -37.00K | -37.00K | -79.00K |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | 0.00 | 0.00 | 0.00 |
| Cash from Financing | 35.25M | 21.23M | 15.09M | 14.86M | 244.00K |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 5.20M | 6.17M | -6.52M | -1.64M | -7.35M |